HK Stock Market Move | Great Wall Motor (02333) falls over 3% as September auto sales decline 13.99% year-on-year; institutions say the company's profitability is expected to recover from the second half of the year
Great Wall Motor (02333) fell over 3%, down 2.86% as of press time to HK$6.625, with a turnover of HK$46.2934 million.
Great Wall Motor (02333) fell over 3%, down 2.86% as of press time to HK$6.625, with turnover of HK$46.2934 million.
On the news front, Great Wall Motor recently announced that in September 2026, total vehicle sales were approximately 114,900 units, down 13.99% year-on-year; production was approximately 121,100 units, down 9.9% year-on-year. For January-September, total vehicle sales were approximately 920,300 units, down 0.33% year-on-year; total production was approximately 975,300 units, up 6.04% year-on-year.
SDIC International Securities noted that Great Wall Motor's January-September cumulative sales of 920,000 units, down 0.3% year-on-year, saw cumulative growth shift from an increase in the first half to broadly flat, with Ora's cumulative doubling being the only bright spot. The bank believes that overseas localized production capacity and channel expansion will continue to contribute incremental volume, and the company's profitability is expected to recover from the second half of the year.
Related Articles
SSY GROUP (02005): Labetalol Hydrochloride Has Been Approved by the National Medical Products Administration for Registration as an Active Pharmaceutical Ingredient Used in Marketed Formulations
TRANSTHERA-B (02617): Jieentai has issued its first clinical prescriptions in multiple provinces, with simultaneous stocking completed at DTP pharmacies in multiple locations nationwide.
HK Stock Market Move | SHIMAO GROUP (00813) fell more than 21% in the morning session; has entered into a sale and purchase agreement with the buyer to dispose of hotel-related business for a total consideration of HK$2.7 billion.
SSY GROUP (02005): Labetalol Hydrochloride Has Been Approved by the National Medical Products Administration for Registration as an Active Pharmaceutical Ingredient Used in Marketed Formulations
TRANSTHERA-B (02617): Jieentai has issued its first clinical prescriptions in multiple provinces, with simultaneous stocking completed at DTP pharmacies in multiple locations nationwide.
HK Stock Market Move | SHIMAO GROUP (00813) fell more than 21% in the morning session; has entered into a sale and purchase agreement with the buyer to dispose of hotel-related business for a total consideration of HK$2.7 billion.
